Medplus Health Services Limited (NSE:MEDPLUS) — Market Cap & Net Worth
Market Cap & Net Worth: Medplus Health Services Limited (MEDPLUS)
Medplus Health Services Limited (NSE:MEDPLUS) has a market capitalization of $1.10 Billion (Rs102.11 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #8643 globally and #424 in its home market, demonstrating a -0.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medplus Health Services Limited's stock price Rs850.90 by its total outstanding shares 120003381 (120.00 Million). Review MEDPLUS liabilities breakdown to assess the company's total debt and financial obligations.
Medplus Health Services Limited Market Cap History: 2021 to 2026
Medplus Health Services Limited's market capitalization history from 2021 to 2026. Data shows change from $1.35 Billion to $1.10 Billion (-5.96% CAGR).
Index Memberships
Medplus Health Services Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.15 Trillion | 0.10% | #240 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.24 Trillion | 0.03% | #359 of 750 |
Weight: Medplus Health Services Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Medplus Health Services Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medplus Health Services Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Medplus Health Services Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.70x
Medplus Health Services Limited's market cap is 0.70 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.35 Billion | $30.69 Billion | $638.58 Million | 0.04x | 2.11x |
| 2022 | $796.32 Million | $37.79 Billion | $958.02 Million | 0.02x | 0.83x |
| 2023 | $974.32 Million | $45.58 Billion | $497.63 Million | 0.02x | 1.96x |
| 2024 | $1.08 Billion | $56.25 Billion | $654.73 Million | 0.02x | 1.65x |
| 2025 | $1.05 Billion | $61.36 Billion | $1.50 Billion | 0.02x | 0.70x |
Competitor Companies of MEDPLUS by Market Capitalization
Companies near Medplus Health Services Limited in the global market cap rankings as of June 19, 2026.
Key companies related to Medplus Health Services Limited by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1706 globally with a market cap of $14.35 Billion USD ( €12.27 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2203 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2574 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3306 globally with a market cap of $5.68 Billion USD ( R$28.94 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1706 | JD HEALTH INTL LTD | F:8ZN | $14.35 Billion | €3.82 |
| #2203 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2574 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3306 | Raia Drogasil S.A | SA:RADL3 | $5.68 Billion | R$16.55 |
Medplus Health Services Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Medplus Health Services Limited's market cap moved from $1.35 Billion to $ 1.10 Billion, with a yearly change of -5.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.10 Billion | +5.40% |
| 2025 | Rs1.05 Billion | -2.83% |
| 2024 | Rs1.08 Billion | +10.67% |
| 2023 | Rs974.32 Million | +22.35% |
| 2022 | Rs796.32 Million | -40.85% |
| 2021 | Rs1.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Medplus Health Services Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.10 Billion USD |
| MoneyControl | $1.10 Billion USD |
| MarketWatch | $1.10 Billion USD |
| marketcap.company | $1.10 Billion USD |
| Reuters | $1.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more